Risk Analysis in Healthcare Organizations: Methodological Framework and Critical Variables.

consequences-likelihood analysis healthcare risk analysis risk matrix

Journal

Risk management and healthcare policy
ISSN: 1179-1594
Titre abrégé: Risk Manag Healthc Policy
Pays: England
ID NLM: 101566264

Informations de publication

Date de publication:
2021
Historique:
received: 01 03 2021
accepted: 10 05 2021
entrez: 16 7 2021
pubmed: 17 7 2021
medline: 17 7 2021
Statut: epublish

Résumé

A risk assessment matrix is a widely used tool for analyzing, assessing and setting priorities in risk management in many fields. This paper overviews critical variables, advantages, disadvantages, strengths and weaknesses of this tool, according to the ISO 31000 risk management framework. Risk assessment is one of the key stages in the Risk Management Process and involves specific steps: identifying hazards, analyzing and evaluating all possible risks. Several methods are developed to assess risks in the literature. A risk matrix method, also called "decision matrix risk assessment (DMRA) technique", is a systematic approach used to determine the risk level and to compare different risks and define which threats need to be controlled first. The actors involved in risk assessment are called on to manage different issues related to the choice of the most appropriate methodological approach, the assessment of the adequacy of the existing control measures, the articulation of risk consequence domains, the definition of the impact-consequences, the explanation of risk likelihood scales and the development of a risk matrix. We highlighted a number of recommendations in order to address these issues, especially useful when healthcare organizations provide insufficient guidance on how to use risk matrices as well as what to do in response to the existing criticisms on their use.

Identifiants

pubmed: 34267567
doi: 10.2147/RMHP.S309098
pii: 309098
pmc: PMC8275831
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

2897-2911

Informations de copyright

© 2021 Pascarella et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

J Hazard Mater. 2008 Nov 15;159(1):152-7
pubmed: 18440700
Risk Anal. 2015 Aug;35(8):1437-47
pubmed: 25958890
Risk Anal. 2014 Aug;34(8):1469-81
pubmed: 24341726
Risk Anal. 2018 Jan;38(1):99-117
pubmed: 28403567
Risk Anal. 2019 May;39(5):1060-1070
pubmed: 30395689
Risk Anal. 2008 Apr;28(2):497-512
pubmed: 18419665
Open Med Inform J. 2017 Sep 14;11:37-43
pubmed: 29204226
Crit Rev Food Sci Nutr. 2018 Jan 22;58(2):178-193
pubmed: 26857813
Int J Environ Res Public Health. 2015 Aug 14;12(8):9575-88
pubmed: 26287224

Auteurs

Giacomo Pascarella (G)

Scientific Directorate, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Napoli, Italy.

Matteo Rossi (M)

Wroclaw School of Banking Wyższa Szkoła Bankowa, Wrocalw, Poland.

Emma Montella (E)

Department of Public Health, Università Federico II, Napoli, Italy.

Arturo Capasso (A)

Wroclaw School of Banking Wyższa Szkoła Bankowa, Wrocalw, Poland.

Gianfranco De Feo (G)

Scientific Directorate, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Napoli, Italy.

Gerardo Botti (G)

Scientific Directorate, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Napoli, Italy.

Antonio Nardone (A)

Department of Public Health, Università Federico II, Napoli, Italy.

Paolo Montuori (P)

Department of Public Health, Università Federico II, Napoli, Italy.

Maria Triassi (M)

Department of Public Health, Università Federico II, Napoli, Italy.

Stefania D'Auria (S)

Department of Health Management, Istituto Nazionale Tumori, "Fondazione G. Pascale", IRCCS, Napoli, Italy.

Alessandro Morabito (A)

Thoracic Department, Istituto Nazionale Tumori "Fondazione G. Pascale" IRCCS, Napoli, Italy.

Classifications MeSH